Brief: Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287
08/01/2025 13:55
Jan 8 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS ANNOUNCES FORMATION OF CLINICAL ADVISORY
BOARD
TO SUPPORT CONTINUED ADVANCEMENT OF LEAD DRUG CANDIDATE GT-02287
Source text: urn:newsml:reuters.com:*:nGNX3X5Zbf
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall